Diagnostics & Research

Exact Sciences sees increase in ownership as Forsta AP Fonden adds new position during third quarter

☀️Trending News Exact Sciences ($NASDAQ:EXAS) is a medical technology company that is focused on developing and commercializing diagnostic tests for [...]

Caredx Stock Intrinsic Value – HC Wainwright Raises Q3 2024 EPS Estimates for CareDx, Following Positive Research Analysis

☀️Trending News CAREDX ($NASDAQ:CDNA): CareDx, Inc. is a leading precision medicine company that specializes in providing innovative transplant solutions for [...]

Neogenomics Stock Fair Value Calculation – NeoGenomics’ Neo Comprehensive™ Solid Tumor Test Receives New York State Approval, Expanding Access to Advanced Cancer Diagnostics

🌧️Trending News NEOGENOMICS ($NASDAQ:NEO): NeoGenomics, Inc. is a leading provider of cancer diagnostics and genetic testing services, based in FT. [...]

By |October 29, 2024|Categories: Diagnostics & Research, Intrinsic Value|Tags: , , |0 Comments

TMO Intrinsic Value Calculation – Thermo Fisher Scientific Receives “Moderate Buy” Rating from Analysts

🌥️Trending News Thermo Fisher Scientific ($NYSE:TMO) is a leading global biotechnology company that provides a wide range of scientific and [...]

By |October 26, 2024|Categories: Diagnostics & Research, Intrinsic Value|Tags: , , |0 Comments

Exact Sciences Intrinsic Value – Exact Sciences Corp shares drop by 3.11% in mid-day trading on Oct 21

🌥️Trending News Exact Sciences ($NASDAQ:EXAS) Corp is a leading biotechnology company that specializes in developing non-invasive cancer screening tests. Their [...]

By |October 26, 2024|Categories: Diagnostics & Research, Intrinsic Value|Tags: , , |0 Comments

Twist Bioscience Stock Fair Value – Twist Bioscience receives “Moderate Buy” recommendation from top brokerages for its shares

☀️Trending News Twist Bioscience ($NASDAQ:TWST) is a leading synthetic biology company that specializes in producing high-quality synthetic DNA for a [...]

By |October 26, 2024|Categories: Diagnostics & Research, Intrinsic Value|Tags: , , |0 Comments

Leerink Partners lowers price target for Guardant Health, but maintains “outperform” rating on stock

🌧️Trending News Guardant Health ($NASDAQ:GH) is a precision oncology company that specializes in developing and commercializing blood tests for early [...]

By |October 24, 2024|Categories: Diagnostics & Research, Market Price|Tags: , , |0 Comments
Go to Top